The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases.
about
The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: implications in neurological disorders.The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9.Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain.Sigma-1 Receptor Antagonists: A New Class of Neuromodulatory Analgesics.Sigma-1 and N-Methyl-d-Aspartate Receptors: A Partnership with Beneficial Outcomes.Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on MigraineEndocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction.The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control.Schizophrenia and depression, two poles of endocannabinoid system deregulation.Cannabinoid-glutamate interactions and neural oscillations: implications for psychosis.Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process.Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice.Sigma-1 Receptor and Pain.Sigma 1 Receptor Antagonists Inhibit Manic-like Behaviors in Two Congenital Strains of Mice.Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors.Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor
P2860
Q34675713-B9E0A899-76B9-45D0-86CE-EAEC5D0D9B7DQ38262682-A65AEC45-AE91-41E2-8B7A-AA18BAE5A22CQ38639528-C63D6C9F-5612-47E7-898F-8D54FCAD396EQ38896666-7C4A09F5-F2AC-4181-ABB2-A99D737BF409Q39158236-9898C19B-3C08-4A3C-BFFA-FA4ED6DCCD7CQ41289215-40876BCA-5996-4870-8647-BDE0CE932CBEQ41572995-8D3B818A-8164-4654-973E-7D2DAC4B77E5Q42317501-77DB7A17-4EBF-4B40-90DB-393758A906E7Q43195386-48D72A4D-57F7-4F8A-A9A1-F97BDC80688CQ47284001-8F73B051-5C59-4F96-B06B-40412220DCFEQ47299109-5DA4E409-3054-4CE7-8BC6-DEA14378910FQ52318138-B82BD9E6-506D-43C4-9962-E4C8E542D9D2Q53443172-0A6A9E48-2D0A-417D-BF41-9746CAD9894CQ53647635-B5C5F346-9809-4C8D-BFAB-174A881D8E7AQ54977290-1DE1CF02-F07E-45BC-AA0F-B3DA0C5C0E74Q55340475-F92F7856-0902-4FA6-9653-1E435B94A62BQ58732614-3DA33E6E-C7EE-42DE-835D-0E08361DD401
P2860
The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
The calcium-sensitive Sigma-1 ...... eption and psychotic diseases.
@en
The calcium-sensitive Sigma-1 ...... eption and psychotic diseases.
@nl
type
label
The calcium-sensitive Sigma-1 ...... eption and psychotic diseases.
@en
The calcium-sensitive Sigma-1 ...... eption and psychotic diseases.
@nl
prefLabel
The calcium-sensitive Sigma-1 ...... eption and psychotic diseases.
@en
The calcium-sensitive Sigma-1 ...... eption and psychotic diseases.
@nl
P2093
P2860
P921
P1476
The calcium-sensitive Sigma-1 ...... eption and psychotic diseases.
@en
P2093
Daniel Zamanillo
Javier Burgueño
Javier Garzón
Pilar Sánchez-Blázquez
Raquel Herrero-Labrador
P2860
P304
P356
10.1017/S1461145714000029
P577
2014-01-31T00:00:00Z